… In fact more recently, a long-term study conducted in obese subjects with glucose alterations
and subclinical inflammation treated with etanercept, TNF-α antagonist, found an improved …

… Obese subjects show endothelial dysfunction, including resistance to insulin-mediated
vasodilatation, so implying vascular insulin resistance. Indeed it has been suggested that this …

… of the mechanisms linking obesity with the metabolic syndrome and other complications.
Obesity is characterized by a chronic, systemic low-grade state of inflammation. Biomarkers of …

… and cellular inflammatory markers associated with obesity-related metabolic disorders that
… Molecular mechanisms underlying this inflammatory activation state will be reviewed and …

… recognize specific antigens in fat. Identification of specific antigens could lead to novel
therapeutic strategies aimed at preventing adipose inflammation in obese subjects. One potential …

… to type 2 diabetes obese subjects led to a reduction … metabolic syndrome subjects resulted
in an increase in muscle adiposity, but TNF antagonism in patients with severe inflammatory …

… , metabolic factors, inflammatory markers, and vascular reactivity in obese subjects with
metabolic syndrome … -sectional study of 19 obese subjects with metabolic syndrome and 8 lean …

… Bastard and associates demonstrated that IL-6 levels in obese subjects and in type 2 … that
in obese humans, plasma concentrations of adiponectin are lower than in non-obese subjects.…

… marker concentration with increasing thigh subcutaneous fat (20). … obese men and women
with metabolic syndrome had significantly higher levels of inflammatory cytokines than obese …

… inflammatory markers, it supports the emphasis we are giving to adipose tissue in metabolic
syndrome-associated chronic inflammation [… fat diets, frequently consumed by obese subjects…